Mankind Pharma Q4

Mankind Pharma Q4 PAT up 52 pc at Rs 294 cr

Mankind Pharma on Wednesday reported 52 per cent increase in consolidated profit after tax (PAT) at Rs 294 crore for March quarter 2022-23, aided by robust sal...